Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-26-001267

Chief Executive Officer bought 50,571 shares at an average $1.96 ($99,176)

  • Chief Executive Officer acquired 10,016 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nijhawan Pardeep · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-26 Purchase : show line 1 in the form +20,571 $1.58 $32,480 615,797 D
2026-03-02 Grant or award : show line 2 in the form +10,016 625,813 D
2026-02-27 Purchase : show line 3 in the form +30,000 $2.22 $66,696 371,702 I
Open-market purchases · 50,571 sh · avg $1.96 · $99,176
Loading xslF345X05/ownership.xml…